Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Cardiovascular Considerations in COVID19: A Comprehensive Review

Authors Keihanian F, Bigdelu L

Received 28 May 2020

Accepted for publication 20 October 2020

Published 11 November 2020 Volume 2020:16 Pages 1089—1097


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 5

Editor who approved publication: Professor Garry Walsh

Faeze Keihanian,1,2 Leila Bigdelu1,3

1Cardiovascular Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; 2Pharmaceutical Research Center, Booali Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; 3Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Correspondence: Leila Bigdelu Tel +98 5138400000
Fax +98 5138453239

Abstract: Coronavirus disease 2019 (COVID19) is spreading rapidly and there is now much concern regarding different aspects of public health. Underlying disorders like cardiovascular diseases can increase the mortality rate. Understanding cardiovascular complications, manifestations and management in COVID19 is a necessary need. In this comprehensive review, we evaluated different aspects of cardiovascular disorders or complications related to COVID19 infection.

Keywords: SARS-CoV-2, COVID-19, cardiovascular diseases, complication

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]